Trial · NCT06211036
Registered outcomes28
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 28
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | OS | Up to approximately 3 years | |
| Secondary | Progression Free Survival (PFS) | Up to approximately 3 years | |
| Secondary | Overall Response (OR) | Up to approximately 3 years | |
| Secondary | Disease Control (DC) Rate | Up to approximately 3 years | |
| Secondary | Duration of Response (DoR) | Up to approximately 3 years | |
| Secondary | PFS at 6 Months | 6 months | |
| Secondary | PFS at 1 Year | 1 year | |
| Secondary | PFS at 2 Years | 2 years | |
| Secondary | OS at 6 Months | 6 months | |
| Secondary | OS at 1 Year | 1 year | |
| Secondary | OS at 2 Years | 2 years | |
| Secondary | OS at 3 Years | 3 years | |
| Secondary | Time to Progression (TTP) | Up to approximately 3 years | |
| Secondary | Number of Participants with Treatment-emergent Adverse Events (TEAEs) | Up to approximately 9 months | |
| Secondary | Number of Participants with TEAEs Grade 3 or Above per Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0. | Up to approximately 3 years | |
| Secondary | Number of Participants with Serious TEAEs | Up to approximately 3 years | |
| Secondary | Number of Participants with TEAEs Leading to Discontinuation of Treatment | Up to approximately 3 years | |
| Secondary | Number of Participants with Fatal TEAEs | Up to approximately 3 years | |
| Secondary | Number of Participants with Treatment-related Adverse Events (AEs) | Up to approximately 9 months | |
| Secondary | Number of Participants with Adverse Events of Interest (EOI) | Up to approximately 9 months |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06211036/registered